-
公开(公告)号:US20050131014A1
公开(公告)日:2005-06-16
申请号:US11010236
申请日:2004-12-10
申请人: Michael Collini , Robert Singhaus , Baihua Hu , James Jetter , Robert Morris , David Kaufman , Christopher Miller , John Ullrich , Rayomand Unwalla , Jay Wrobel , Elaine Quinet , Ponnal Nambi , Ronald Bernotas , Merle Elloso
发明人: Michael Collini , Robert Singhaus , Baihua Hu , James Jetter , Robert Morris , David Kaufman , Christopher Miller , John Ullrich , Rayomand Unwalla , Jay Wrobel , Elaine Quinet , Ponnal Nambi , Ronald Bernotas , Merle Elloso
IPC分类号: A61K31/47 , A61K31/4709 , C07D215/14 , C07D215/54 , C07D401/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D405/04 , C07D405/06 , C07D405/12 , C07D409/04 , C07D409/06 , C07D409/12 , C07D413/04 , C07D413/06 , C07D417/12 , C07D41/02
CPC分类号: C07D401/04 , C07D215/14 , C07D215/54 , C07D401/06 , C07D401/12 , C07D401/14 , C07D405/04 , C07D405/06 , C07D405/12 , C07D409/04 , C07D409/06 , C07D409/12 , C07D413/04 , C07D413/06 , C07D417/12
摘要: This invention provides compounds of formula I that are useful in the treatment or inhibition of LXR mediated diseases.
摘要翻译: 本发明提供可用于治疗或抑制LXR介导的疾病的式I化合物。
-
公开(公告)号:US08519107B2
公开(公告)日:2013-08-27
申请号:US12915445
申请日:2010-10-29
申请人: Juan Carlos Almagro , Daniela Della Ducata , Merle Elloso , Jinquan Luo , Thomas Malia , Michael Naso , Galina Obmolova , Robert Rauchenberger , Mark Rutz , Raymond Sweet , Susann Taudte , Bingyuan Wu , Sheng-Jiun Wu
发明人: Juan Carlos Almagro , Daniela Della Ducata , Merle Elloso , Jinquan Luo , Thomas Malia , Michael Naso , Galina Obmolova , Robert Rauchenberger , Mark Rutz , Raymond Sweet , Susann Taudte , Bingyuan Wu , Sheng-Jiun Wu
CPC分类号: C07K16/244 , C07K2317/33 , C07K2317/34 , C07K2317/56 , C07K2317/76 , C07K2317/92
摘要: Interleukin-17A (IL-17A) antibody antagonists, polynucleotides encoding IL-17A antibody antagonists or fragments thereof, and methods of making and using the foregoing are disclosed.
摘要翻译: 公开了白介素-17A(IL-17A)抗体拮抗剂,编码IL-17A抗体拮抗剂或其片段的多核苷酸,以及制备和使用前述物质的方法。
-
公开(公告)号:US20110236390A1
公开(公告)日:2011-09-29
申请号:US12915445
申请日:2010-10-29
申请人: Juan Carlos Almagro , Daniela Della Ducata , Merle Elloso , Jinquan Luo , Thomas Malia , Michael Naso , Galina Obmolova , Robert Rauchenberger , Mark Rutz , Raymond Sweet , Susann Taudte , Bingyuan Wu , Sheng-Jiun Wu
发明人: Juan Carlos Almagro , Daniela Della Ducata , Merle Elloso , Jinquan Luo , Thomas Malia , Michael Naso , Galina Obmolova , Robert Rauchenberger , Mark Rutz , Raymond Sweet , Susann Taudte , Bingyuan Wu , Sheng-Jiun Wu
IPC分类号: A61K39/395 , C12N15/63 , C12N5/10 , C07K16/24 , C12N1/00 , C07H21/00 , C07K1/107 , A61P29/00 , A61P11/00 , A61P17/06 , A61P11/06 , A61P19/02
CPC分类号: C07K16/244 , C07K2317/33 , C07K2317/34 , C07K2317/56 , C07K2317/76 , C07K2317/92
摘要: Interleukin-17A (IL-17A) antibody antagonists, polynucleotides encoding IL-17A antibody antagonists or fragments thereof, and methods of making and using the foregoing are disclosed.
摘要翻译: 公开了白细胞介素-177(IL-17A)抗体拮抗剂,编码IL-17A抗体拮抗剂或其片段的多核苷酸,以及制备和使用前述物质的方法。
-
公开(公告)号:US07576215B2
公开(公告)日:2009-08-18
申请号:US11010236
申请日:2004-12-10
申请人: Michael D. Collini , Robert R. Singhaus, Jr. , Baihua Hu , James W. Jetter , Robert L. Morris , David H. Kaufman , Christopher P. Miller , John W. Ullrich , Rayomand J. Unwalla , Jay E. Wrobel , Elaine Quinet , Ponnal Nambi , Ronald C. Bernotas , Merle Elloso
发明人: Michael D. Collini , Robert R. Singhaus, Jr. , Baihua Hu , James W. Jetter , Robert L. Morris , David H. Kaufman , Christopher P. Miller , John W. Ullrich , Rayomand J. Unwalla , Jay E. Wrobel , Elaine Quinet , Ponnal Nambi , Ronald C. Bernotas , Merle Elloso
IPC分类号: C07D215/38
CPC分类号: C07D401/04 , C07D215/14 , C07D215/54 , C07D401/06 , C07D401/12 , C07D401/14 , C07D405/04 , C07D405/06 , C07D405/12 , C07D409/04 , C07D409/06 , C07D409/12 , C07D413/04 , C07D413/06 , C07D417/12
摘要: This invention provides compounds of formula I that are useful in the treatment or inhibition of LXR mediated diseases.
摘要翻译: 本发明提供可用于治疗或抑制LXR介导的疾病的式I化合物。
-
-
-